Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03886155 · ClinicalTrials.gov registry record
Cardiac Amyloidosis Screening at Trigger Finger Release
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 107
- Enrollment target
NCT03886155: Completed study, sponsored by The Cleveland Clinic.
NCT03886155 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03886155 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
The investigators will prospectively evaluate for the presence of amyloid deposits in soft tissue samples obtained from patients undergoing trigger finger release surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.
Primary Outcome
Incidence of amyloid deposits in soft tissue removed from trigger finger tenosynovium in older patients undergoing trigger finger release surgery
Interventions
- PROCEDURE Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-12-02 |
What the finished NCT03886155 record still lists
NCT03886155 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Biopsy is the first listed.
NCT03886155 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03886155 about?
NCT03886155 is a clinical study titled "Cardiac Amyloidosis Screening at Trigger Finger Release". The investigators will prospectively evaluate for the presence of amyloid deposits in soft tissue samples obtained from patients undergoing trigger finger release surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.
What is the current status of trial NCT03886155?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2019-05-01. Estimated completion is 2021-12-02.
What interventions are being tested in trial NCT03886155?
The interventions under investigation include: Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03886155?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI